RPGRIP1 and retinal degeneration: To date, the clinical literature on RPGRIP1-LCA patients clearly documents early and severe visual disturbances with nystagmus, abnormal visual acuity, nondetectable ERGs, and fundus features of retinal degeneration [22,23].